Welltrients for Life, Inc. Where Wellness & Nutrients come Together. Do not be Brain Dead be Be Welltrient Smart
  Wellness Advantage ™
LoginID:
Password
Tuesday, December 10th, 2024   We believe in Two great powers: the power of Nature and the power within one´s self.
Home   Food Science   Health Sciences   Mind & Body Concepts   Sick Care Systems (Health Care Systems)   Plant Sciences   Alchemy Center   Back  
Hepatocellular Carcinoma |14923|
See Also ↔
 
 
“Hepatocellular Cancer (Hepatocellular Carcinoma)”  

Hepatocellular Carcinoma

  In our body's liver, the liver dis-ease, Hepatocellular Carcinoma is a primary malignant liver neoplasm indicative to a specific set of signs, symptoms or other health indicators, associated with this serious health challenge of epithelial liver cells.
  In our body's liver, Hepatocellular Carcinoma is associated with the down regulation of the HEPN1 gene and suppressed GLYAT gene expression.
  In our body's liver, the cancer called Hepatocellular Carcinoma is frequently associated with abnormalities in cell cycle regulation, characterized by high cellular levels of cyclin-dependent kinases (Cdks), leading to increased activity of cyclin-dependent kinases (Cdks) due to the loss, or low expression of CDK inhibitors (Cyclin-Dependent Kinase Inhibitors), also associated with an infectious associated disease linked or correlated with at least one infectious pathogen. *
[14949]
 
References & Citations:
1. "About Our Genes in PMID"    
2. "About Our Genes in PMID"    
3. Chua MS. et al "Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinom"   Anticancer Res. 2006 May-Jun;26(3A):1739-43  
4. Lin ZY. et al "Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines"   Biomed Pharmacother. 2010 May;64(5):348-51  
5. Sunagozaka H. et al "Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma"   Int J Cancer. 2011 Oct 1;129(7):1576-85  
6. Cho SJ. et al "Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells"   J Biol Chem. 2011 Jun 3;286(22):19662-71  
7. Matsuo M. et al "Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma"   Biochem Biophys Res Commun. 2012 Apr 20;420(4):901-6  
 
    The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.